The 3 analysts offering 12-month price forecasts for American Renal Associates Holdings Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +44.46% increase from the last price of 6.23.
The current consensus among 3 polled investment analysts is to Hold stock in American Renal Associates Holdings Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.21
Reporting Date May 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.